Celltrion’s Vegzelma overtakes Roche’s Avastin in Europe Celltrion’s metastatic colorectal and breast cancer treatment Vegzelma (bevacizumab) has surpassed Roche’s original drug Avastin, becoming the most… Cheon Okhyeon 2025-02-05